Key Players in the Pharmaceuticals Industry in Brazil¶
Key Players Table¶
| Detailed profile | Relevant context information | Estimates of volumes | Estimates of revenue |
|---|---|---|---|
| Grupo NC (includes EMS): A major Brazilian pharmaceutical group. Based on 2024 data, it holds the leading position in sales to pharmacies in Brazil. | Controlador da EMS, lidera o mercado brasileiro em vendas para farmácias. Apresentou um crescimento de 9.6% em 2024. | Not available | R$ 26.4 billion (2024 sales to pharmacies) |
| Eurofarma: A significant pharmaceutical company operating in Brazil. Showed substantial growth in 2024 and climbed to the second position in sales to pharmacies. | Apresentou um crescimento de receita de 22.4% em 2024, a segunda maior alta entre as top 10, pulando para a segunda posição em vendas para farmácias. | Not available | Ranked 2nd in 2024 sales to pharmacies (specific revenue not provided) |
| Hypera: A prominent player in the Brazilian pharmaceutical market, previously holding the second position in sales to pharmacies. | Teve uma evolução de 7.3% na receita em 2024, ficando na terceira posição em vendas para farmácias. Vem apostando na estratégia da diversificação, buscando ganhar fôlego na categoria de medicamentos de especialidades, além de ser referência na venda de MIPs. | Not available | Ranked 3rd in 2024 sales to pharmacies (specific revenue not provided) |
| Novo Nordisk: A global pharmaceutical company with a strong presence and significant growth in Brazil. | Apresentou um crescimento de 23.2% em 2024, uma das maiores altas entre as top 10. Entrou no top 3 em vendas de medicamentos de prescrição (Rx) em 2023, impulsionada por medicamentos para diabetes e off-label. | Not available | Significant growth in 2024 (specific revenue not provided), likely in the top 10 overall sales to pharmacies. |
| Takeda: A global pharmaceutical company with operations in Brazil, listed among the top players in Rx sales in 2023. | Classificada no top 10 de laboratórios por faturamento em vendas Rx no Brasil em 2023. | Not available | Ranked in top 10 Rx sales in 2023 (specific revenue not provided), likely in the top 10 overall sales to pharmacies in 2024. |
| Bayer: A multinational life science company with a pharmaceuticals division active in Brazil, listed among the top players in Rx sales in 2023. | Classificada no top 10 de laboratórios por faturamento em vendas Rx no Brasil em 2023. | Not available | Ranked in top 10 Rx sales in 2023 (specific revenue not provided), likely in the top 10 overall sales to pharmacies in 2024. |
| Novartis: A global healthcare company with a pharmaceutical segment, active in the Brazilian market and listed among the top players in Rx sales in 2023. | Classificada no top 10 de laboratórios por faturamento em vendas Rx no Brasil em 2023. Also a global top pharmaceutical company. | Not available | Ranked in top 10 Rx sales in 2023 (specific revenue not provided), likely in the top 10 overall sales to pharmacies in 2024. |
| Aché: A Brazilian pharmaceutical company, listed among the top players in Rx sales in 2023. | Classificada no top 10 de laboratórios por faturamento em vendas Rx no Brasil em 2023. | Not available | Ranked in top 10 Rx sales in 2023 (specific revenue not provided), likely in the top 10 overall sales to pharmacies in 2024. |
| Sanofi: A global healthcare company with a significant presence in Brazil, listed among the top players in Rx sales in 2023. | Classificada no top 10 de laboratórios por faturamento em vendas Rx no Brasil em 2023. Also a global top pharmaceutical company. | Not available | Ranked in top 10 Rx sales in 2023 (specific revenue not provided), likely in the top 10 overall sales to pharmacies in 2024. |
| AstraZeneca: A global biopharmaceutical company with operations in Brazil, listed among the top players in Rx sales in 2023 and showed significant growth in Rx revenue. | Classificada no top 10 de laboratórios por faturamento em vendas Rx no Brasil em 2023. Teve uma evolução de 26.6% na receita com Rx em 2023, impulsionada pelo medicamento Forxiga. Also a global top pharmaceutical company. | Not available | Ranked in top 10 Rx sales in 2023 (specific revenue not provided), likely in the top 10 overall sales to pharmacies in 2024. |
Note: While the table lists the top 10 based on available information for 2024 sales to pharmacies and 2023 Rx sales ranking, precise 2024 revenue figures for all companies beyond the top one were not available in the provided sources. Volume estimates for individual players were also not detailed in the provided sources.
References¶
- Dez maiores farmacêuticas do Brasil detêm 48,6% das vendas - Abradilan. https://vertexaisearch.cloud.google.com/grounding-api-redirect/AWQVqAK4dBmW7IL9RJrghI81NrTydx17jDcvLPcJ4rnNRn2f5n8GkMkcFku27e0pt7zAEFjLiJqaY4vDTnyw0BSDp4BDXTX-8HtzLrfoLRx6vssa4XhvxFLdf1kLe4rqa3Hry-GwhRsD4GId0WAZJ2LjBMwewmueCX0nlRG2UtSnxK0xQDM38Z_dcEoRtcqly7wpDf2bEEQq
- Dez maiores farmacêuticas detêm 48,6% das vendas - Abradilan. https://vertexaisearch.cloud.google.com/grounding-api-redirect/AWQVqALpXuNxLNuYpAUq48iyrcyWHkTee43sqtPbo5sKgazL_0uOyljDTRCA20arcXfsQkJYHlIuPwNOJg3jZVTbD-R3p4AVQuAUnr6LPsZOeTb_BMvq_xKG8mpXhhyTJdAMl1xnbkCfpigFP4VOzx4pu0KpSCRF92zXOLs4jHN9PKMaoOiEo-0RLXfJUkHIQc-DnT-xyvA=
- Dez maiores laboratórios do Brasil têm 55% do mercado - Panorama Farmacêutico. https://vertexaisearch.cloud.google.com/grounding-api-redirect/AWQVqAJdgOgJGT-yf6Xs8QSu2zs9sQJmCXVtGknZ-HFxiDNByocwokIi8kRjvxbYiHuUkkpCMs2onZLzrxjYfKyd4xmMna3UvFh3-iG3xsANWmt4NElBiepjjKSnmEdSLc2FXhunY7-f0EfzOSKtf_ALZ1Mrsj5t8Wa58iR6__yDG3WI1Q==